Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Recommendation of “Hold” from Analysts

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been given an average rating of “Hold” by the fifteen brokerages that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, five have given a hold recommendation, seven have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $26.8462.

ACHC has been the topic of a number of analyst reports. Guggenheim lifted their target price on shares of Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Leerink Partners lifted their price target on shares of Acadia Healthcare from $14.00 to $22.00 and gave the company a “market perform” rating in a report on Thursday, February 26th. Barclays lifted their price target on shares of Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Thursday, April 30th. Cantor Fitzgerald boosted their price objective on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. Finally, Jefferies Financial Group raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their target price for the company from $24.50 to $30.00 in a research report on Wednesday, June 3rd.

Acadia Healthcare Trading Up 4.1%

NASDAQ:ACHC opened at $24.89 on Friday. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare has a 12 month low of $11.43 and a 12 month high of $30.20. The company has a market cap of $2.29 billion, a PE ratio of -2.03, a price-to-earnings-growth ratio of 7.97 and a beta of 0.69. The company has a 50 day simple moving average of $25.50 and a two-hundred day simple moving average of $20.00.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million for the quarter, compared to analysts’ expectations of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company’s revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Research analysts forecast that Acadia Healthcare will post 1.5 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of ACHC. Wellington Management Group LLP raised its stake in Acadia Healthcare by 24.9% in the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after purchasing an additional 2,350,760 shares during the last quarter. Vanguard Group Inc. boosted its stake in Acadia Healthcare by 7.8% during the 3rd quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock worth $233,166,000 after purchasing an additional 681,278 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after buying an additional 3,815,471 shares in the last quarter. Abrams Bison Investments LLC boosted its holdings in Acadia Healthcare by 22.3% in the 3rd quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock valued at $108,449,000 after purchasing an additional 800,000 shares during the last quarter. Finally, UBS Group AG boosted its holdings in Acadia Healthcare by 8.8% in the 3rd quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock valued at $107,377,000 after purchasing an additional 350,484 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.